Sleep Medicine Reviews
Volume 14, Issue 2 , Pages 121-129 , April 2010

Sleep disorders in patients with multiple sclerosis

  • Steven D. Brass

      Affiliations

    • Co-Director of Sleep Medicine, Department of Neurology, UC Davis School of Medicine, 4860 Y Street, Suite 0100, Sacramento, CA 95817, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 916 734 3588, +1 916 703 5078.
    • ,
  • Pierre Duquette

      Affiliations

    • Medical Director of Multiple Sclerosis Clinic, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke Street E, Montreal, Quebec, Canada H2L 4M1
    • ,
  • Joëlle Proulx-Therrien

      Affiliations

    • Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke Street E, Montreal, Quebec, Canada H2L 4M1
    • ,
  • Sanford Auerbach

      Affiliations

    • Director of Sleep Medicine, Department of Neurology, Boston University, 720 Harrison Avenue, Suite 707, Boston, MA 02118, USA

References* 

  1. Multiple Sclerosis Society America . Frequently asked questions [Internet]. [cited 02/24/2009]. Available from: http://www.msassociation.org/faq/#question-62009;
  2. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34(6):320–323
  3. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12(4):481–486
  4. Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med. 2009;10(1):26–34
  5. Kaynak H, Altintaş A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13(12):1333–1339
  6. Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol. 2004;61(4):525–528
  7. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008;14(8):1127–1130
  8. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131–136
  9. Patel SR, Redline S. Two epidemics: are we getting fatter as we sleep less?. Sleep. 2004;27(4):602–603
  10. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380–384
  11. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205–209
  12. American Academy of Sleep Medicine . In:  Winkleman J,  Kotagal S,  Olson E,  Scammel T,  Schenk C editor. International classification of sleep disorders: diagnostic and coding manual. 2nd ed.. Westchester, IL: American Academy of Sleep Medicine; 2005;
  13. Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Koskimies S, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol. 1994;35(6):709–716
  14. Iseki K, Mezaki T, Oka Y, Terada K, Tomimoto H, Miki Y, et al. Hypersomnia in MS. Neurology. 2002;59(12):2006–2007
  15. Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand. 1963;39:252–256
  16. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310
  17. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology. 1980;30(1):105–108
  18. Vetrugno R, Stecchi S, Plazzi G, Lodi R, D'Angelo R, Alessandria M, et al. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med. 2009;10:389–391
  19. Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology. 1991;41(3):447–448
  20. Poirier G, Montplaisir J, Dumont M, Duquette P, Décary F, Pleines J, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987;37(4):693–695
  21. Oka Y, Kanbayashi T, Mezaki T, Iseki K, Matsubayashi J, Murakami G, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol. 2004;251(7):885–886
  22. Duquette P, Décary F, Pleines J, Boivin D, Lamoureux G, Cosgrove JB, et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci. 1985;12(2):106–110
  23. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142(3):187–197
  24. Clanet MG, Brassat D. The management of multiple sclerosis patients. Curr Opin Neurol. 2000;13(3):263–270
  25. Ferini-Strambi L, Filippi M, Martinelli V, Oldani A, Rovaris M, Zucconi M, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci. 1994;125(2):194–197
  26. Trojan DA, Da Costa D, Bar-Or A, Benedetti A, Lapierre Y, Arnold DL et al. Sleep abnormalities in multiple sclerosis patients. Mult Scler 2008;14: S160.
  27. Ajayi OF, Chang-McDowell T, Culpepper II WJ, Royal W, Bever CT. High prevalence of sleep disorders in veterans with multiple sclerosis. Neurology 2008;50:P06.141
  28. Arnulf I, Derenne JP. Respiratory disorders during sleep in degenerative diseases of the brain stem. Rev Neurol. 2001;157(11 Pt 2):S148–S151
  29. Howard RS, Wiles CM, Hirsch NP, Loh L, Spencer GT, Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain. 1992;115(Pt 2):479–494
  30. Stankiewicz JA, Pazevic JP. Acquired Ondine's curse. Otolaryngol Head Neck Surg. 1989;101(5):611–613
  31. Severinghaus JW, Mitchell RA. Ondine's curse - failure of respiratory center automaticity while awake. Clin Res. 1962;10:122
  32. Chaudhary BA, Elguindi AS, King DW. Obstructive sleep apnea after lateral medullary syndrome. South Med J. 1982;75(1):65–67
  33. Askenasy JJ, Goldhammer I. Sleep apnea as a feature of bulbar stroke. Stroke. 1988;19(5):637–639
  34. Auer RN, Rowlands CG, Perry SF, Remmers JE. Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). Clin Neuropathol. 1996;15(2):101–105
  35. Levin BE, Margolis G. Acute failure of automatic respirations secondary to a unilateral brainstem infarct. Ann Neurol. 1977;1(6):583–586
  36. Nogués MA, Roncoroni AJ, Benarroch E. Breathing control in neurological diseases. Clin Auton Res. 2002;12(6):440–449
  37. Rizvi SS, Ishikawa S, Faling LJ, Schlessinger L, Satia J, Seckel B. Defect in automatic respiration in a case of multiple sclerosis. Am J Med. 1974;56(4):433–436
  38. Chervin RD, Guilleminault C. Diaphragm pacing: review and reassessment. Sleep. 1994;17(2):176–187
  39. Chervin RD, Guilleminault C. Diaphragm pacing for respiratory insufficiency. J Clin Neurophysiol. 1997;14(5):369–377
  40. Bassetti CL, Gugger M. Sleep disordered breathing in neurologic disorders. Swiss Med Wkly. 2002;132(9–10):109–115
  41. Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–1279
  42. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res. 1997;31(3):333–346
  43. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry. 1997;58(8):369–376quiz 377
  44. Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3(5):437–439
  45. Gómez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13(6):805–808
  46. Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006;67(5):742–747
  47. Taphoorn MJ, van Someren E, Snoek FJ, Strijers RL, Swaab DF, Visscher F, et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol. 1993;240(7):446–448
  48. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci. 2000;20(22):8620–8628
  49. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP, Vitiello MV, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep. 2007;30(11):1460–1483
  50. Ekbom KA. Restless legs syndrome. Neurology. 1960;10:868–873
  51. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4:101-119.
  52. Hening WA, Allen RP, Chaudhuri KR, Hornyak M, Lee HB, Winkelman J, et al. Clinical significance of RLS. Mov Disord. 2007;22(Suppl. 18):S395–S400
  53. Auger C, Montplaisir J, Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology. 2005;65(10):1652–1653
  54. Manconi M, Fabbrini M, Bonanni E, Filippi M, Rocca M, Murri L, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol. 2007;14(5):534–539
  55. Manconi M, Rocca MA, Ferini-Strambi L, Tortorella P, Agosta F, Comi G, et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler. 2008;14(1):86–93
  56. Deriu M, Cossu G, Molari A, Murgia D, Mereu A, Ferrigno P, et al. Restless legs syndrome in multiple sclerosis: a case–control study. Mov Disord. 2009;24:697–701
  57. Moreira NCV, Damasceno RS, Medeiros CAM, de Bruin PFC, Teixeira CAC, Horta WG, et al. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res. 2008;41(10):932–937
  58. Michaud M, Paquet J, Lavigne G, Desautels A, Montplaisir J. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol. 2002;48(2):108–113
  59. Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet. 2008;40(8):946–948
  60. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22(Suppl. 18):S440–S448
  61. Brass SD, Chen NK, Mulkern RV, Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging. 2006;17(1):31–40
  62. Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep. 2000;23(3):361–367
  63. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric. 2008;11(5):422–428
  64. Italian REMS Study Group , Manconi M, Ferini-Strambi L, Filippi M, Bonanni E, Iudice A, et al. Multicenter case–control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep. 2008;31(7):944–952
  65. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504
  66. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22(Suppl. 2):S347–S353
  67. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol. 1996;53(12):1270–1275
  68. O'Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain. 2008;137(1):96–111
  69. Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol. 1992;49(6):641–643
  70. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A, Kryger M. Cytokines and pathological sleep. Sleep Med. 2008;9(6):603–614
  71. Payne LC, Krueger JM. Interactions of cytokines with the hypothalamus–pituitary axis. J Immunother. 1992;12(3):171–173
  72. Krueger JM, Obál FJ, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001;933:211–221
  73. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci U S A. 2007;104(31):12843–12848
  74. Payne LC, Obál F, Krueger JM. Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J Cell Biochem. 1993;53(4):309–313
  75. Obál F, Fang J, Payne LC, Krueger JM. Growth-hormone-releasing hormone mediates the sleep-promoting activity of interleukin-1 in rats. Neuroendocrinology. 1995;61(5):559–565
  76. Opp MR, Krueger JM. Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol. 1994;266(3 Pt 2):R688–R695
  77. Opp MR, Smith EM, Hughes TK. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol. 1995;60(1–2):165–168
  78. Kushikata T, Fang J, Wang Y, Krueger JM. Interleukin-4 inhibits spontaneous sleep in rabbits. Am J Physiol. 1998;275(4 Pt 2):R1185–R1191
  79. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. J Neurol Neurosurg Psychiatry. 2006;77(1):34–39
  80. Heesen C, Koehler G, Gross R, Tessmer W, Schulz KH, Gold SM. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Mult Scler. 2005;11(1):51–57
  81. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 1990;40(11):1735–1739
  82. Heesen C, Gold SM, Raji A, Wiedemann K, Schulz KH. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology. 2002;27(4):505–517
  83. Bourne RS, Mills GH. Sleep disruption in critically ill patients-pharmacological considerations. Anaesthesia. 2004;59(4):374–384
  84. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. 4th ed.. Saunders; 2005;[Text with Continually Updated Online Reference]
  85. Kotterba S, Eren E, Fangerau T, Malin JP, Sindern E. Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments, Fortschr Neurol Psychiatr. 2003;71(11):590–594
  86. MacAllister WS, Krupp LB. Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am. 2005;16(2):483–502
  87. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435–437
  88. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000;6(3):181–185
  89. Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology. 1999;53(5):1151–1153
  90. Lapierre Y, Hum S. Treating fatigue. Int MS J. 2007;14(2):64–71
  91. Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117–129
  92. Benbadis SR, Mascha E, Perry MC, Wolgamuth BR, Smolley LA, Dinner DS. Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population. Ann Intern Med. 1999;130(4 Pt 1):289–292
  93. Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest. 2000;118(2):372–379
  94. Strober LB, Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol. 2005;20(5):631–646
  95. Culebras A. Other neurological disorders. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 883. Available at: www.sleepmedtext.com
  96. Markowitz CE. Interferon-beta: Mechanism of action and dosing issues. Neurology. 2007;68:S8–S11
  97. Schweitzer PK. Drugs that disturb sleep. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 509–11. Available at: www.sleepmedtext.com
  98. Sioka JS. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Multiple Sclerosis. 2005;11(4):425–432
  99. Mitler MM, O'Malley MB. Wake-promoting medications: efficacy and adverse effects. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 488–9. Available at: www.sleepmedtext.com
  100. Nishino S, Mignot E. Wake-promoting medications: basic mechanisms and pharmacology. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 468–76. Available at: www.sleepmedtext.com
  101. Korenke AR. Sustained-Release Fampridine for Symptomatic Treatment of Multiple Sclerosis. The Annals of Pharmacotherapy. 2008;42(10):1458–1465
  102. Mignot E. Narcolepsy: pharmacology, pathophysiology, and genetics. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 763–5. Available at: www.sleepmedtext.com
  103. Finnimore AJ, et al. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J. 1995;8:230–234
  104. Mendelson WB. Hypnotic medications: mechanisms of action and pharmacology effects. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 449–51. Available at: www.sleepmedtext.com
  105. Tanaka H, et al. Effects of tizanidine for refractory sleep disturbance in disabled children with spastic quadriplegia. No To Hattatsu. 2004;36(6):455–460
  106. Schweitzer PK. Drugs that disturb sleep. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 499–504. Available at: www.sleepmedtext.com
  107. Buysse DJ, Schweitzer PK, Moul DE. Clinical pharmacology of other drugs used as hypnotics. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: WB Saunders; 2005;p. 459–64. Available at: www.sleepmedtext.com
  108. Diefenbach K, et al. Randomised, double blind study of the effects of oxybutynin, toiterodine, trospium chloride and placebo on sleep in healthy young volunteers. Clinical drug investigation. 2003;23(6):395–404

PII: S1087-0792(09)00070-7

doi: 10.1016/j.smrv.2009.07.005

Sleep Medicine Reviews
Volume 14, Issue 2 , Pages 121-129 , April 2010

Article Tools

* Image Usage & Resolution